
EoxSense is an innovative health-tech startup focused on real-time biosensing. The company combines advanced electrochemical sensing, custom low-cost electronics, and intelligent data pipelines to deliver next-generation biosensing platforms. Their non-invasive sensors are designed to measure multiple biomarkers, such as Lactate and Glucose, from sweat. These sensors are battery-free, compact, and communicate via Bluetooth and NFC, feeding data into a secure cloud-based AI for personalized insights. The company targets athletes, optimizers, and trailblazers who seek real-time clarity for peak performance. EoxSense emphasizes a consumer-first approach, aiming to make proactive health monitoring simple and accessible, with a business model likely centered around the sale of sensors and associated data services.

EoxSense is an innovative health-tech startup focused on real-time biosensing. The company combines advanced electrochemical sensing, custom low-cost electronics, and intelligent data pipelines to deliver next-generation biosensing platforms. Their non-invasive sensors are designed to measure multiple biomarkers, such as Lactate and Glucose, from sweat. These sensors are battery-free, compact, and communicate via Bluetooth and NFC, feeding data into a secure cloud-based AI for personalized insights. The company targets athletes, optimizers, and trailblazers who seek real-time clarity for peak performance. EoxSense emphasizes a consumer-first approach, aiming to make proactive health monitoring simple and accessible, with a business model likely centered around the sale of sensors and associated data services.
Founded: 2022
Product: Self-powered, skin-integrated sweat biosensors that non‑invasively measure biomarkers (e.g., lactate, glucose) and stream data wirelessly to a cloud/AI layer
Funding: Pre-Seed (Apr 18, 2023) led by Grow Venture Partners — total disclosed funding: 137,187 USD
Team size & leadership: Around 7 employees; leadership includes CEO Pär Blanking and CTO Pascal Blondeau
| Company |
|---|
Wearable biosensing and real-time health/performance monitoring using non-invasive sweat-based biomarker measurement.
2022
Biotechnology
Listed as last round; company describes closing an initial private seed investment in 2023.
Debt financing entry reported in March 2024 (amount not disclosed).
“Supported by Grow Venture Partners (lead in Apr 2023 round); partners/support logos also include ACCIÓ and Enisa”